Original news and analysis on international IP policy
The heads of the patent offices of China, Europe, Korea, Japan and the United States met today and declared artificial intelligence one of the top strategic priorities for them as a group. Other efforts included work on harmonising patent practices, the Global Dossier program, classification of new technologies, and patents and standards, according to a release.
Frederick Abbott writes: On 20 May 2018, US Treasury Secretary Mnuchin announced that the US and China were “putting the trade war on hold” while the two countries seek to “execute the framework” of a broad agreement intended to reduce the US trade deficit in goods with China. According to the joint statement issued on 19 May 2018, “Both sides attach paramount importance to intellectual property protections, and agreed to strengthen cooperation. China will advance relevant amendments to its laws and regulations in this area, including the Patent Law.”
A new “virtual assistant” used by the Australian Intellectual Property Office may be able in the future to read the facial expressions of trademark filers and provide them with solutions - with empathy.
On 1 April 2013, in a packed room inside India’s Supreme Court, a magnificent building in Indo-British architectural style, two judges delivered a verdict that impacted the national and global conversation about patents and patients. India’s apex court delivered a 112-page landmark judgement which dismissed Swiss pharma giant Novartis AG’s appeal for a patent for its life-saving cancer drug marketed under brand name Glivec in most parts of the world. The Novartis case triggered a hugely polarising discourse around the world about a key feature of India’s patent regime.
For a variety of reasons, Thailand and Brazil have huge backlogs of pharmaceutical patent applications. The delay in patent examinations is creating pressure on the countries to extend patent protection terms to the detriment of access to affordable medicines, AIDS organisations say.
Access to affordable medicines is one of the most pressing policy issues globally. India has played a prominent role as “pharmacy of the developing world” with its generic medicine industry; however, the interpretation and implementation of a particular section of the law can significantly affect this role, according to a recent study.
Many hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position toward the high prices of medicines, as high-income countries were also faced with an untenable burden to their health systems. In a number of lower and middle-income countries, civil society organised itself to increase access to sofosbuvir for millions in need.
BANGKOK - Transnational drug manufacturers’ tactics of obtaining unmerited patent applications have unnecessarily raised healthcare costs and impeded the growth of domestic generic drug industry, costing the Thai government hundreds of millions of dollars, drug access campaigners and local producers have said.
The United States Patent and Trademark Office has attachés around the world specialised in intellectual property issues, including but not limited to enforcement. The office today announced an opening for a new attaché to be located in New Delhi, India, a key post.
A group of Asian countries is working towards a regional agreement on electronic commerce. During the United Nations Conference on Trade and Development e-commerce week, less developed countries of this group explained the difficult catch-up they have to fully enter into e-commerce nationally and internationally, particularly because most of their companies are small. Transport businesses, meanwhile, called for special customs rules for small companies to ease their participation in global e-commerce.
The sharing economy is booming, disrupting conventional ways of doing business, creating new jobs, and new headaches for policymakers. China is promoting the sharing economy as a national strategy, as explained during the annual United Nations Conference on Trade and Development (UNCTAD) electronic commerce event this week, and illustrated by DiDi Chuxing, a leading Chinese mobile-based transportation platform.
This time Donald Trump was correct: China has, for years, unfairly obtained and exploited American intellectual property and technology. But Trump’s response – imposing $50 billion in tariffs annually on a wide variety of Chinese imports – is problematic, experts warn. The tariffs appear to violate World Trade Organization rules, undermine the international rules-based economic order that has served the West well for decades, and threaten to ignite a trade war between the world’s two biggest economies.